Adding Ultralow-Dose Naltrexone to Oxycodone Enhances and Prolongs Analgesia: A Randomized, Controlled Trial of Oxytrex

This publication has 20 references indexed in Scilit:

• Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects
  Pain, 2004
• Ultra-Low Dose Oral Naltrexone Decreases Side Effects and Potentiates the Effect of Methadone
  Journal of Pain and Symptom Management, 2003
• The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period
  Pain, 2002
• Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials
  Clinical Therapeutics, 2001
• Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions
  Trends in Pharmacological Sciences, 1998
• Opioid-sparing Effects of a Low-dose Infusion of Naloxone in Patient-administered Morphine Sulfate
  Anesthesiology, 1997
• Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
  Proceedings of the National Academy of Sciences, 1995
• Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of ‘protracted opioid dependence’
  Brain Research, 1995
• After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside
  Brain Research, 1992
• Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons
  Trends in Pharmacological Sciences, 1990